Veradigm (MDRX) Stock Price & Analysis
MDRX Stock Chart & Stats
- Day’s Range
- $4.75 - $4.95
- 52-Week Range
- $3.25 - $5.60
- Previous Close
- $4.90
- Volume
- N/A
- Average Volume (3M)
- 89.95K
- Market Cap
- $523.16M
- Enterprise Value
- $1.00B
- Total Cash (Recent Filing)
- $492.60M
- Total Debt (Recent Filing)
- $218.81M
- Price to Earnings (P/E)
- ―
- Beta
- 0.11
- Next Earnings
- Feb 25, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Veradigm News
Veradigm Lawsuit Ruling: Securities Claims Against MDRX, Former Executives Move Forward in Part
A federal judge in Illinois has allowed key investor claims against Veradigm Inc. (MDRX) and two former senior executives to proceed, while dismissing claims against another former executive and the company’s former
MDRX FAQ
What was Veradigm’s price range in the past 12 months?
What is Veradigm’s market cap?
When is Veradigm’s upcoming earnings report date?
How were Veradigm’s earnings last quarter?
Is Veradigm overvalued?
Does Veradigm pay dividends?
What is Veradigm’s EPS estimate?
How many shares outstanding does Veradigm have?
What happened to Veradigm’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Veradigm?
What is the TipRanks Smart Score and how is it calculated?
Veradigm Stock Smart Score
Company Description
Veradigm
Veradigm Inc. is a global healthcare technology enterprise that delivers cutting-edge information technology platforms to a diverse client base, including healthcare providers, health plans (payers), and biopharmaceutical companies, operating across the United States and various international markets. For healthcare providers, the company offers a suite of integrated solutions designed to optimize operations. These include Practice Management software, AI-driven Patient Scheduling tools, and systems for Electronic Statements and Payments. Veradigm also provides comprehensive revenue cycle management, encompassing specialized services and a dedicated clearinghouse to streamline financial workflows. Furthermore, their electronic health records (EHR) portfolio features advanced options like ePrescribe with EPCS, Veradigm HER, and Practice Fusion HER, complemented by a robust Patient Engagement Platform. The firm extends its offerings to network partners through a variety of connectivity solutions. These comprise API integration tools such as Veradigm Connect and Veradigm App Expo, a Diagnostic Ordering and Resulting Network, a Channel Partner Program, and Veradigm ePrescribe Enterprise. Health plans and payers benefit from Veradigm's specialized solutions, which include sophisticated risk adjustment tools like Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics. They also provide quality management systems, including quality analytics and integrated risk adjustment and quality management features. Data exchange and coding solutions, such as eChart Courier, eChart Coder, and eChart Integration and Analytics, further enhance efficiency. Additionally, Veradigm offers provider engagement platforms like Veradigm Payer Insights and the comprehensive Veradigm Payerpath suite. For the biopharma sector, Veradigm supplies valuable real-world data solutions, including extensive health datasets and specialized registries for cardiology and metabolic conditions. This is coupled with real-world evidence platforms, such as the Real World Evidence Analytics Platform. Therapy-focused data is available for key areas like cardiovascular, central nervous system, metabolic, and immunology. The company also delivers Digital Health Media solutions. Established in 1986 and headquartered in Chicago, Illinois, Veradigm Inc. was previously known as Allscripts Healthcare Solutions, Inc., before rebranding to its current name in January 2023.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Donald D. Trigg
- Employees
- 2,300
- Website
- veradigm.com
- Address
- 222 Merchandise Mart Plaza, Chicago, IL, 60654, US
Veradigm (MDRX) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 2 | 16 |
| Technical Analysis | 2 | 2 | 6 |
| Moving Averages | 2 | 0 | 10 |
